Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,832 | 4,103 | 2,221 | 7,233 | 3,441 |
| Depreciation Amortization | 2,923 | 1,897 | 920 | 3,452 | 2,341 |
| Income taxes - deferred | -11,031 | 235 | 34 | 469 | -53 |
| Accounts receivable | 550 | -43 | -481 | 3,233 | 3,386 |
| Accounts payable and accrued liabilities | -193 | 356 | 240 | -1,024 | -1,597 |
| Other Working Capital | -2,204 | -805 | -623 | 5,206 | 1,500 |
| Other Operating Activity | 1,167 | 449 | 797 | -2,060 | 120 |
| Operating Cash Flow | $8,044 | $6,192 | $3,108 | $16,509 | $9,138 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -593 | -408 | -204 | -1,372 | -820 |
| Net Acquisitions | -6,115 | -1,485 | N/A | -20,764 | -12,812 |
| Other Investing Activity | -376 | -364 | -324 | -164 | -135 |
| Investing Cash Flow | $-7,084 | $-2,257 | $-528 | $-22,300 | $-13,767 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,350 | 2,500 | N/A | 16,900 | 9,000 |
| Debt Repayment | -5,662 | -4,661 | -1,508 | -3,674 | -1,365 |
| Common Stock Issued | 194 | 179 | N/A | 271 | 112 |
| Common Stock Repurchased | -5,000 | -1,751 | N/A | -2,404 | -2,404 |
| Other Financing Activity | 0 | 0 | 0 | -1,308 | 0 |
| Financing Cash Flow | $-118 | $-3,733 | $-1,508 | $9,785 | $5,343 |
| Exchange Rate Effect | -213 | -1,071 | -617 | -1,104 | 233 |
| Beginning Cash Position | 16,588 | 16,588 | 16,588 | 13,698 | 13,698 |
| End Cash Position | 17,217 | 15,719 | 17,043 | 16,588 | 14,645 |
| Net Cash Flow | $629 | $-869 | $455 | $2,890 | $947 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,044 | 6,192 | 3,108 | 16,509 | 9,138 |
| Capital Expenditure | -615 | -431 | -204 | -1,376 | -820 |
| Free Cash Flow | 7,429 | 5,761 | 2,904 | 15,133 | 8,318 |